ChiCTR2200062096: Safety and Tolerability of VGR-R01 in Patients with Bietti Crystalline Dystrophy |
|
|
| Not yet recruiting | N/A | 3 | | Administration of VGR-R01 via subretinal injection, with concomitant use of immunosuppressive medication | Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Shanghai Vitalgen Biopharma Co.,Ltd. | Bietti Crystalline Dystrophy | | | | |
